UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway.
Renal cell carcinoma (RCC) is the most common primary malignancy of the kidney and one of the most lethal genitourinary malignancies. Clear-cell renal cell carcinoma (ccRCC) has an extremely poor prognosis because of a high potential for tumor growth, vascular invasion, metastasis and recurrence. Un...
Main Authors: | Ji Ling Wen, Xiao Fei Wen, Rong Bing Li, Yong Chao Jin, Xue Lei Wang, Lan Zhou, Hui Xing Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4319909?pdf=render |
Similar Items
-
UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway
by: Wenjing Hu, et al.
Published: (2021-09-01) -
The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression
by: Nicole Pui Yu Ho, et al.
Published: (2021-02-01) -
Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy
by: Sarah-Kim Bisson, et al.
Published: (2018-01-01) -
Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling
by: Chen Hang, et al.
Published: (2021-01-01) -
CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
by: Qi Wang, et al.
Published: (2021-10-01)